A5101805898- interferon and immune responses
- COVID-19 Clinical Research Studies
- Advanced Radiotherapy Techniques
- Viral Infections and Immunology Research
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Outbreaks Research
- Gallbladder and Bile Duct Disorders
- Radiomics and Machine Learning in Medical Imaging
- Mesenchymal stem cell research
- Cancer-related molecular mechanisms research
- Lung Cancer Diagnosis and Treatment
- RNA modifications and cancer
- Curcumin's Biomedical Applications
- Biliary and Gastrointestinal Fistulas
- Biomedical Ethics and Regulation
- Long-Term Effects of COVID-19
- Respiratory viral infections research
- Autophagy in Disease and Therapy
- Virus-based gene therapy research
- RNA Interference and Gene Delivery
- Cholangiocarcinoma and Gallbladder Cancer Studies
Wuhan University
2025
Chinese PLA General Hospital
2024
Soochow University
2024
The First People's Hospital of Changzhou
2024
University of Iowa
2007
Background: Liver cancer remains to be one of the leading causes worldwide. The treatment options face several challenges and nanomaterials have proven improve bioavailability drug candidates their applications in nanomedicine. Specifically, chitosan nanoparticles (CNPs) are extremely biodegradable, pose enhanced biocompatibility considered safe for use medicine. Methods: CNPs were synthesized by ionic gelation, loaded with rutin (rCNPs) characterized ultraviolet–visible spectroscopy...
SARS-CoV-2 monoclonal antibodies remain the only option for prevention or treatment of COVID-19 those with immunodeficiencies drug interactions antiviral agents. Here, we assess neutralizing activity authorized antibody pemivibart and candidate SA55 against major historical currently dominant viral variants, including JN.1 subvariants KP.3.1.1 XEC. Our findings show that demonstrates broad potency while exhibits reduced variants. Then employ replication-competent vesicular stomatitis virus...
Background The lncRNA TRG-AS1 and its co-expressed gene P2RY10 are important for colorectal cancer (CRC) occurrence development. purpose of our research was to explore the roles in CRC progression.
Objective: To investigate the clinical efficacy and safety of 125I seed implantation in treatment mediastinal lymph node metastasis lung cancer. Methods: Clinical data 36 patients who underwent CT-guided for cancer from August 2013 to April 2020 three hospitals Northern radioactive particle collaboration group were retrospectively collected, including 24 males 12 females, aged 46 84 years. Cox regression model was used analyze relationship between local control rate, survival rate tumor...
Objective: To investigate the value of integrated pancreatic and biliary stents for prevention post-Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis. Methods: The clinical data patients whom had post-ERCP pancreatitis from December 2013 to October 2015 were retrospectively analyzed. effect complication compared between straight group group. Results: A total 214 Among them, 139 received a with average operation time 62.1±9.8 min 75 67.2±12.7 min. was statistically...
Restricted accessAbstractFirst published March 2007Subversion of Type I Interferon Antiviral Defense in Human Airway Epithelial Cells by Adenovirus InfectionL. Shi, M. Ramaswamy, […], L.J. Manzel, and D.C. Look+1-1View all authors affiliationsVolume 55, Issue 2https://doi.org/10.1177/108155890705500261